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Abstract
A 66-year-old man with a diagnosis of monoclonal gammopathy of unknown significance was referred
for investigation of bilateral transudative pleural effusions by the cardiology team. Echocardiography,
myocardial perfusion scanning and left heart catheterisation were all normal or non diagnostic. Given
significant occupational asbestos exposure in his twenties he underwent thoracoscopic pleural biopsy.
Thisshowedfibrousinflammationonly.Hesubsequentlydevelopedproteinuriaandperipheraloedema.
Reanalysis of the pleural biopsy specimen for amyloidosis was positive. Pleural disease is an uncommon
presentationofsystemicamyloidosis.Theaetiologyofthepleuraleffusionsisunclearandisnotsimplya
consequence of cardiac or renal impairment.
Case presentation
A 66-year-old white British man was referred from the
cardiology team to the respiratory out-patient clinic for
investigation of progressive breathlessness, unexplained
bilateral pleural effusions and weight loss. Echocardio-
graphy had shown good left and right ventricular function,
no significant valvular disease, normal E/A ratio and
normal cardiac structure. No reversible ischaemia was seen
at myocardial perfusion scanning. Left heart catheterisa-
tion showed only minor (30%) stenosis in the left anterior
descending coronary artery and normal left ventriculo-
gram. Medical history revealed hypertension, IgG kappa
monoclonal gammopathy of undetermined significance
(MGUS) for 5 years and strong occupational asbestos
exposure whilst working in the building trade in his
twenties. Pleural fluid analysis on two occasions demon-
strated a transudative effusion by Light’s criteria (pleural
protein 30 g/l, serum protein 91 g/l and lactate dehydro-
genase 61 IU/l). There were no malignant cells on
cytological examination. Thyroid function tests were
within the normal reference ranges. Computed tomogra-
phy of the chest showed only bilateral pleural effusions
with no evidence of bronchial malignancy, prior asbestos
exposure, interstitial disease, pulmonary embolus or
pleural malignancy (Figure 1). He underwent video
assisted thoracoscopic pleural examination and talc
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(page number not for citation purposes)pleurodesis. The operative note reported ‘abnormal
nodular pleural change’ which was biopsied. This showed
non-specific chronic inflammatory change with fibrosis.
There were several areas of hyalinized collagenous plaques
in keeping with the strong history of asbestos exposure,
but no malignant disease. Post-operative recovery was
complicated by myocardial infarction, pulmonary
oedema, small pulmonary emboli, frank haematuria and
continued weight loss. He then developed marked
dependent oedema despite supportive enteral feeding via
a nasogastric tube. Serum albumin was 22 g/l, urea and
creatinine were within the normal reference ranges and
urinalysis quantified 1.3 g/24 hours of proteinuria. The
potential diagnoses were reviewed in light of the changing
findings and discussed with the histopathologist. The
original sample was reanalysed with Congo red stain. This
is not part of our routine histological staining of pleural
biopsies. The areas of fibrosis showed the classic apple
green birefringence of amyloid deposition when viewed
under high-intensity cross polarised light (Figure 2).
A diagnosis of systemic AL amyloidosis was made. He
was reviewed by specialist colleagues at the National
Amyloidosis Centre and commenced on oral dexametha-
sone and melphalan. He remained unwell with poor
performance status and despite supportive therapy died 4
months after diagnosis.
Discussion
Amyloidosis is a multisystem disease characterised by the
deposition of abnormal insoluble protein in tissues in-
cluding the pleural space [1] disrupting organ function.
Classically amyloidosis is divided into two main groups,
AL amyloid in which the abnormal protein is from
immunoglobulin light chain fragments or AA amyloid in
which the fibrils are derived from serum amyloid
A produced as a consequence of chronic inflammatory
processes. MGUS in addition to progressing on to multiple
myeloma is a recognised potential cause for systemic
AL amyloidosis [2].
Pleural effusions in systemic amyloidosis are rare, large
effusions, occupying over one-third of the hemithorax on
chest radiograph were reported in 6% of cases of AL
amyloidosis in the largest single centre experience
published [3]. To be the presenting feature and source of
the diagnostic biopsy for amyloidosis is unusual. Pleural
effusions have often been considered purely epipheno-
mena secondary to cardiac dysfunction both systolic and
diastolic, or proteinuria and hypoalbuminaemia due to
renal involvement. The last review of amyloidosis and the
respiratory tract in the journal of the British Thoracic
Society, Thorax did not discuss the pleural space [4].
Direct amyloid infiltration of the pleural surfaces disrupt-
ing the balance between generation and removal of
pleural fluid seems to be responsible for forming and
maintaining pleural effusions in systemic amyloidosis.
Cardiomyopathy plays a part in their development but is
not sufficient in isolation [5].
In those with cardiac amyloid and ‘persisting pleural
effusions’ (PPE), defined as being refractory to diuresis,
Berk et al conclude that ‘neither echocardiographic
measures of ventricular function nor the degree of
nephrosis distinguished those with PPEs’. In addition
those with PPEs ineligible for treatment had a very poor
prognosis, with a median survival of just 1.8 months [3].
This is in keeping with our patient’s disease progression.
Figure 1. Computed tomography of the chest showing
bilateral pleural effusions without other significant
thoracic disease.
Figure 2. Congo red stain of pleural biopsy specimen
showing the apple green birefringence of amyloid when
seen under polarised light.
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Cases Journal 2009, 2:6963 http://casesjournal.com/casesjournal/article/view/6963In conclusion, systemic amyloidosis should be considered
as a potential cause of unexplained pleural effusions. It can
be diagnosed on pleural biopsy, as emphasised by our
experience it requires suspicion of the diagnosis in order
the correct histological test is performed and it is difficult
to treat. The case emphasises the importance of reviewing
evolving diagnostic dilemmas in a multidisciplinary
forum and reassessing old tests and samples in the light
of a changing clinical picture.
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